Navco Pharmaceuticals Inc.
NAV.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.40K | 1.00K | 5.40K | 8.20K | 15.90K |
| Total Receivables | -- | 37.70K | 49.20K | 52.80K | 46.20K |
| Inventory | -- | -- | -- | 1.40K | 1.40K |
| Prepaid Expenses | -- | -- | -- | 36.20K | 73.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.40K | 38.60K | 54.60K | 98.50K | 136.60K |
|
|
|||||
| Total Current Assets | 13.40K | 38.60K | 54.60K | 98.50K | 136.60K |
| Net Property, Plant & Equipment | 0.00 | 500.00 | 1.00K | 114.90K | 122.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 481.70K | 506.10K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.40K | 39.10K | 55.70K | 695.10K | 765.40K |
|
|
|||||
| Total Accounts Payable | 112.60K | 112.40K | 127.00K | 94.20K | 67.30K |
| Total Accrued Expenses | 18.70K | 23.20K | 23.90K | 10.60K | 29.50K |
| Short-term Debt | 60.00K | 60.60K | 40.30K | 506.80K | 450.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 3.40K | 7.20K | 10.10K | 10.00K |
| Total Finance Division Other Current Liabilities | 438.00K | 442.20K | 491.40K | -- | -- |
| Total Other Current Liabilities | 438.00K | 442.20K | 491.40K | -- | -- |
| Total Current Liabilities | 629.30K | 641.80K | 689.80K | 621.70K | 557.60K |
|
|
|||||
| Total Current Liabilities | 629.30K | 641.80K | 689.80K | 621.70K | 557.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 60.00K | 60.60K | 40.30K | 506.80K | 450.80K |
| Capital Leases | -- | -- | -- | 58.80K | 62.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 629.30K | 641.80K | 689.80K | 680.60K | 619.70K |
|
|
|||||
| Common Stock & APIC | 2.79M | 2.79M | 2.97M | 2.93M | 2.97M |
| Retained Earnings | -3.87M | -3.85M | -4.10M | -3.40M | -3.31M |
| Treasury Stock & Other | 459.50K | 459.00K | 488.80K | 482.50K | 487.70K |
| Total Common Equity | -615.90K | -602.70K | -634.20K | 14.50K | 145.70K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -615.90K | -602.70K | -634.20K | 14.50K | 145.70K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -615.90K | -602.70K | -634.20K | 14.50K | 145.70K |
|
|
|||||